Graduated in Medicine in 1988 at the University of Padua. Pediatrician in 1992. I have been actively involved in pediatric hematology and oncology, especially in chemotherapy for leukemia and lymphoma, supportive care, and early and late effects of treatment, and hematopoietic stem cell transplantation (HSCT).
Appointed in 2009 Director of the Pediatric Hematology and Oncology Unit at the Department of Pediatrics in Verona. Member of the scientific committees of several working groups including Pediatrics (for MASCC), Supportive Care (for SIOP), Aplastic Anemia, Infection (for EBMT), hematopoietic stem cell transplant, Infection, Supportive care (for AIEOP). Appointed in 2005 and 2015 Chairman of the Supportive Care Group and Infection of AIEOP (Italian Association of Pediatric Hematology Oncology), respectively. Appointed in 2010, Chairman of Infectious Diseases Working Party of European Society for Blood and Marrow Transplantation.
Author of more than 200 publications in peer-reviewed journals. Medical advisor of the charities Paul O’Gorman Lifeline (UK) and Lifeline Italia, liaising with and advising pediatric hematology and oncology centers in Russia, Ukraine, Georgia and Kyrgyzstan.
Prof. George P Chrousos is internationally recognized for his research on the glucocorticoid signaling system of the cell, on the diseases of the hypothalamic-pituitary-adrenal axis, and on the physiological and molecular mechanisms of stress. He is one of the 250 most cited scientists internationally (ISI highly cited) included not only in the list of Clinical Medicine, but also in that of Biology and Biochemistry, and the highest cited clinical endocrinologist and pediatrician in the world.
Senior Lecturer in Biological Sciences at the University of Huddersfield, since 2015. Previously Junior Research Fellow, College Lecturer In Biochemistry and various postdocs at the University of Oxford (2013-15). Working on DNA replication, genome integrity and transcription factors in human cancers (and also in prokaryotes). Additional interests in phylogenomics and novel protein expression systems.
Dr José Derraik was born in Rio de Janeiro (Brazil), but moved to New Zealand in 1995. José has a very broad academic background, with a BSc and MSc in Ecology from the University of Otago (New Zealand), and a PhD in Public Health (University of Otago). His MSc examined invertebrate biodiversity in human-modified habitats. His PhD focused on vector ecology, more precisely on mosquitoes in New Zealand and how the threat of a mosquito-borne disease outbreak has been affected by ongoing anthropogenic environmental change. José then worked as a Senior Advisor for MAF Biosecurity NZ, where he provided expert advice to the NZ government on biosecurity threats to human health.
In 2008, José joined the Liggins Institute (University of Auckland) where he has been working on paediatric research, as well as on a number of clinical trials in adolescents and adults at risk of metabolic disease. His research focuses primarily on the long-term effects of early life events (such as preterm or post-term birth) in childhood. However, José has recently been appointed as an honorary research associate at Uppsala University in Sweden, where alongside his Swedish colleagues he has been examining also the long-term effects of early life events in adulthood.
Lastly, José is currently involved in a large multi-institutional project (A Better Start) in New Zealand, with a leading role in a number of studies aiming to predict, prevent, and mitigate childhood obesity in the country.
Chairman of the Dept. of Pediatrics at National Jewish Health in Denver. Vice-Chairman of the Dept. of Pediatrics at the Univ. of Colorado Health Sciences Center. Recipient of the Mead Johnson Award for Research in Pediatrics, the McLaughlin Foundation Edward Gallie Professorship of the Royal College of Physicians and Surgeons of Canada, the Lifetime Achievement Award from National Jewish, and the Honorary Fellow Award from the American Academy of Allergy, Asthma and Immunology.
Consulting biostatistician in the Division of Health Sciences at the University of Otago. In this role, I provide biostatistical expertise to a wide range of researchers on a large number of projects. Much of this is through collaborative relationships as a co-investigator with the remainder through more informal consulting relationships. I have particular interests in obesity research, especially in pediatric populations; nuts as a functional food; respiratory epidemiology; and sun protection. Prior to my current position I was a software metrics and machine learning researcher in the Department of Information Science at the same institution.
Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University.
He leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.
John trained in paediatrics and nephrology in Sydney and London, then worked as an academic paediatric nephrologist at the Royal Alexandra Hospital for Children in Sydney, where he founded the Centre for Kidney Research. For four years he was Medical Director of the Australian Kidney Foundation. Then he worked in therapeutic risk management and pharmacovigilance for a decade for Johnson and Johnson in Europe and Asia. He returned to academia in 2014 as a Professorial Fellow at the George Institute for Global Health in Sydney, where he is also Director of China-Australia Partnerships. His current research concerns dialysis access and outcomes, particularly in resource constrained environments.
Main research Interests:
A) Asthma is a major cause of morbidity in the Western world but curative therapies do not exist. Hence, we aim to understand how early life environmental exposures modify lung development development and the risk of developing asthma throughout life. We use animal models of prenatal exposure to tobacco/nicotine products and human samples.
B) The importance of a steady-state balance of resident and non-resident bacterial communities for human health is increasingly appreciated. Yet, factors driving the composition of such microbial communities remain poorly understood. Therefore, we currently investigate the influence of smoke on the structure and functionality of the lung microbiome and its interaction with the lung health.
Currently Funded Projects
2012 – 2016 Chair of COST Action BM1201 “Developmental origins of Chronic Lung Disease” http://www.cost-early-origin-cld.eu/
2013 – 2016 Understanding the role of the lung microbiome for human health and diseases”, HMGU Environmental Health Projects, Co-PI until move to University of Kiel; Project currently continued on a collaborative basis.
Since 2013 – 2018 PI within German Center for Lung Research www.dzl.de
2016 - 2018 Chair of “The lung Microbiota at the Interface between airway epithelium and the environment” funded by the Leibniz Association
Dr. Sushil Kumar is a Research Assistant professor at the Oregon Health & Science University (OHSU), Portland Oregon. He obtained his PhD from Max Planck Institute for biochemistry, Munich Germany where he worked in supervision of Prof. Axel Ullrich for studying cancer cell signaling. He did his postdoctoral work in Prof. Reto Schwendener’s laboratory at University of Zurich where he developed liposomal drugs for targeted delivery of payloads to macrophages as novel cancer therapy approach. He joined OHSU in 2012 in Prof. Lisa Coussens' laboratory where he has continued his research for studying cancer inflammation and developing immunotherapeutic approaches for cancer. He is employing ex vivo as well as mouse models for understanding immune cell phenotype for analyzing their role in cancer progression and developing novel therapeutics as well as biomarkers for cancer.
Full Professor and Senior Lecturer - Faculty and Nursing, Universidade da Coruña, Spain
Director - Research, Health and Podiatry Unit, Department of Health Sciences, Faculty of Nursing and Podiatry, Universidade da Coruña, Spain
Dr. Moore completed his undergraduate training at Harvard University where he also studied at the MGH Transplantation Biology Research Center (TBRC). He continued his focus in transplantation immunology and autoimmune disease during studies in the MSTP program at the University of Pennsylvania. He subsequently completed his training in pediatrics and pediatric endocrinology at Vanderbilt University Medical Center. His laboratory focus is on the restoration of immune regulation in individuals with autoimmune disease. He pursues this effort through studies on the cellular and molecular biology of effector and regulatory lymphocytes and their responses to tolerance-inducing immune therapies.